Viking Thera
(VKTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,606 | -27,356 | -85,895 | -61,290 | -38,756 |
| Depreciation Amortization | -8,062 | -2,719 | -7,822 | -5,220 | -2,150 |
| Accounts payable and accrued liabilities | 3,577 | -2,287 | -1,018 | -2,819 | -2,919 |
| Other Working Capital | 7,938 | 15,951 | 3,548 | -1,929 | -3,384 |
| Other Operating Activity | 11,506 | 10,277 | 17,811 | 15,522 | 11,131 |
| Operating Cash Flow | $-34,647 | $-6,134 | $-73,376 | $-55,736 | $-36,078 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -585,851 | -459,792 | -179,086 | -214,819 | -202,285 |
| Investing Cash Flow | $-585,851 | $-459,792 | $-179,086 | $-214,819 | $-202,285 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,291 | 4,361 | 6,768 | 6,580 | 6,581 |
| Other Financing Activity | 601,651 | 601,676 | 264,608 | 264,608 | 264,681 |
| Financing Cash Flow | $608,942 | $606,037 | $271,376 | $271,188 | $271,262 |
| Exchange Rate Effect | -45 | -48 | -30 | -80 | -12 |
| Beginning Cash Position | 55,516 | 55,516 | 36,632 | 36,632 | 36,632 |
| End Cash Position | 43,915 | 195,579 | 55,516 | 37,185 | 69,519 |
| Net Cash Flow | $-11,601 | $140,063 | $18,884 | $553 | $32,887 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,647 | -6,134 | -73,376 | -55,736 | -36,078 |
| Free Cash Flow | -34,647 | -6,134 | -73,376 | -55,736 | -36,078 |